CHIMERIX INC. - COMMON STOCK

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Appoints Lisa Decker to Board of Directors

29 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

04 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

24 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

16 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update

02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023

26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"

16 Aug 2023 10:05:00 By Nasdaq GlobeNewswire

Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update

03 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023

27 Jul 2023 07:00:01 By Nasdaq GlobeNewswire

Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer

27 Jun 2023 16:05:00 By Nasdaq GlobeNewswire

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

31 May 2023 16:01:00 By Nasdaq GlobeNewswire

Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House

25 May 2023 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update

04 May 2023 07:00:01 By Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023

27 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting

18 Apr 2023 16:01:00 By Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update

02 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference

28 Feb 2023 16:05:01 By Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023

23 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference

05 Jan 2023 07:00:00 By Nasdaq GlobeNewswire